SSWM
SLXP

Sheets Smith Wealth Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Sheets Smith Wealth Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,380
Closed -$1.62M – 286
2014
Q3 		$1.62M Buy
10,380
+594
+6% +$86.1K 0.44% 69
2014
Q2 		$1.21M Buy
9,786
+2,123
+28% +$235K 0.32% 86
2014
Q1 		$794K Buy
7,663
+773
+11% +$79.1K 0.22% 123
2013
Q4 		$620K Buy
6,890
+3,727
+118% +$297K 0.17% 157
2013
Q3 		$212K Buy
+3,163
New +$218K 0.07% 225

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return